Rankings
▼
Calendar
AMRX Q1 2017 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
Q1 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$226M
Gross Profit
$110M
48.7% margin
Operating Income
$43M
18.9% margin
Net Income
$42M
18.7% margin
EPS (Diluted)
$0.28
QoQ Revenue Growth
-24.4%
Cash Flow
Operating Cash Flow
$69M
Free Cash Flow
$45M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
-$176M
Cash & Equivalents
-$32M
← FY 2017
All Quarters
Q2 2017 →
